Related Experiment Video

Updated: Jun 6, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Malignant peritoneal mesothelioma. Is there a new treatment?

Kakil Ibrahim Rasul1, David J Kerr

  • 1Al-Amal Hospital, Hamad Medical Corporation/Doha, Qatar;

Rare Tumors
|December 9, 2010
PubMed

Abstract:

The authors report a novel, alternative approach to treat malignant peritoneal mesothelioma (MPeM) targeting, vascular endothelial growth factor (VEGF) using anti-VEGF (bevacizumab) chemotherapy combination.

Keywords:
mesotheliomaoncologyrare tumors.

More Related Videos

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Related Experiment Videos

Last Updated: Jun 6, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Articles linked to this work by shared authors, journal, and citation graph.

Reliable classification of polyps based on artificial intelligence: a development and validation study.

EClinicalMedicine·2026

Generalisation of automatic tumour segmentation in histopathological whole-slide images across multiple cancer types.

NPJ precision oncology·2026

Targeting TFAP2β condensation suppresses the development of esophageal squamous cell carcinoma.

Cell·2025

Early-stage lung adenocarcinoma affects DNA methylation and gene expression in adjacent tissues.

EMBO reports·2025

Activin A affects colorectal cancer progression and immunomodulation in a stage dependent manner.

Scientific reports·2025

Long-term outcomes and survival rates of renal cell carcinoma patients in Erbil, Iraq: a follow-up study.

BMC cancer·2025

Spindle cell (sarcomatoid) squamous cell carcinoma of the esophagus: A case report and a review of the literature.

Rare tumors·2026

Pulmonary carcinoid harboring a KRAS G12C mutation identified through comprehensive genomic profiling and responding to sotorasib: A case report.

Rare tumors·2026

Primary hepatic leiomyosarcoma diagnosed after right hepatectomy: A rare case report.

Rare tumors·2026

Prognostic significance of systemic inflammatory indices in squamous cell carcinoma of the anal canal: A retrospective cohort study.

Rare tumors·2026

Chondromyxoid fibroma in a 24-year-old female: A case report highlighting its rarity, diagnostic challenges, and importance of surgical management.

Rare tumors·2026

Vulvar Leiomyoma in a young woman: A case report of a rare benign soft tissue tumor from Woldia, Ethiopia.

Rare tumors·2026

Intranasal essential oils in therapy: advances in clinical applications and delivery mechanisms.

Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan·2026

Immunobridging Analysis of Pemivibart for the Treatment of COVID-19: A Therapeutic Gap for the Immune-Compromised Population Remains.

Open forum infectious diseases·2026

Desferrioxamine attenuating high glucose-induced ferroptosis and inflammatory responses in Müller glial cells via Nrf2/TXNRD1 pathway.

International journal of ophthalmology·2026

Safety and effectiveness of Bian-stone and moxibustion in treatment of meibomian gland dysfunction.

International journal of ophthalmology·2026

Rezvilutamide combined with ADT in an HIV-positive patient with high-volume mHSPC on efavirenz-based antiretroviral therapy: a case report.

Frontiers in oncology·2026

A rhesus macaque model of α-dystroglycanopathy caused by a POMT1 splice altering variant.

Animal models and experimental medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us